Senores Pharmaceuticals Limited — Important, 28-07-2025: General Updates

Senores Pharmaceuticals' key subsidiary, Havix, has successfully completed its USFDA inspection at its manufacturing facility in Georgia, USA. The inspection concluded with 3 procedural and minor 483 observations. Havix is committed to swiftly responding to these observations within 15 days. This outcome is positive for Senores, as it indicates a largely compliant manufacturing process vital for its US market access and continued operations, minimizing potential future regulatory hurdles.